Netherlands· NL-013c52ce6149

Oxcarbazepine ADOH 600 mg, filmomhulde tabletten

A oxcarbazepine product containing oxcarbazepine, registered in Netherlands by ADOH B.V.. The same ATC class is registered in 15 of our 19 countries.

ATC N03AF02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about oxcarbazepineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Oxcarbazepine is registered in 15 of 19 countries.

Countries holding a registration under ATC N03AF02 (oxcarbazepine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search oxcarbazepine products by name

Oxcarbazepine · ATC N03AF02

15 / 19 countries

Belgiumprice
Canada
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxcarbazepine costs, country by country.

Normalised to the WHO defined daily dose (1 g), the median price runs from $0.56 in United States to $2.54 in Switzerland — a ×4.5 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Oxcarbazepine · price per daily dose (1 g)

USD · FX 28 Sept 2026

CH Switzerland$2.54
FR France$1.08
IT Italy$0.73
US United States$0.56 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: OXCARBAZEPINE
Manufacturer: ADOH B.V.
Country: Netherlands (NL)
ATC code: N03AF02
ATC class: Oxcarbazepine
Defined daily dose: 1 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
127893

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

398 interactions on record for oxcarbazepine.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check oxcarbazepine against other medicines How interaction checks work

Oxcarbazepine · interactions on record

398 records

8 severe
263 moderate
7 minor
72 info

Most severe, free to view

Levonorgestrel and ethinylestradiolG03AA07severe
Desogestrel and ethinylestradiolG03AA09severe
Drospirenone and ethinylestradiolG03AA12severe
EthinylestradiolG03CA01severe

48 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxcarbazepine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxcarbazepine products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Trileptal
Belgium · Oxcarbazepine Viatris, Trileptal
Bulgaria · Трилептал
Cyprus · Oxcarbazepine Jubilant, Trileptal
Germany · Apydan Extent, Oxcarbazepin 1 A Pharma
Denmark · Apydan, Oxcarbazepin Jubilant
Estonia · Apydan, Trileptal
Spain · Oxcarbazepina Cinfa, Oxcarbazepina Normon
Finland · Apydan, Oxcarbazepin Orion
France · Oxcarbazepine Sandoz, Oxcarbazepine Viatris
United Kingdom (Northern Ireland) · Oxcarbazepine, Oxcarbazepine Amarox
Greece · Trileptal
Croatia · Trileptal
Hungary · Trileptal
Ireland · Trileptal
Iceland · Oxcarbazepine Jubilant, Trileptal
Italy · Oxcarbazepina Tecnigen, Tolep
Lithuania · Trileptal
Latvia · Trileptal
Norway · Trileptal
Poland · Karbagen, Oxepilax
Portugal · Epilfarmo, Oxcarbazepina Biofarmoz
Romania · Trileptal
Sweden · Trileptal
Slovenia · Karbox
Slovakia · Trileptal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ea3e1c81-30cd-4c22-8c2b-0ec00f9a7bef
GET /v1/drugs/ea3e1c81-30cd-4c22-8c2b-0ec00f9a7bef?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127893_smpc.pdf",
  "strength": null,
  "atc_label": "Oxcarbazepine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127893",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "MACROGOL 8000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "OXCARBAZEPINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127893.pdf",
  "authorised_at": "2022/03/14",
  "procedure_number": "NL/H/5347/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "127893",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about oxcarbazepine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console